SGLT-2 inhibitors, GLP-1 receptor agonists, and DPP-4 inhibitors and risk of hyperkalemia among people with type 2 diabetes in clinical practice: population based cohort study BMJ 2024
Fluid retention may lead to or exacerbate congestive heart failure
It suppresses appetite by acting on brain centers and slows movement of food through the digestive tract
In August 2023, the first lawsuits were filed against Novo Nordisk, the manufacturer of Ozempic and Wegovy, as well as Eli Lilly, the manufacturer of similar GLP-1 agonist drugs
GLP-1 receptors have been found on spinal cord microglia, which are the brain and spinal cords immune cells, and activation of those receptors appears to shift microglia from a pro-inflammatory M1 state to an anti-inflammatory M2 state [2, 16]
Frequently Asked Questions Is it normal for my heart rate to increase when I start semaglutide